Biocompatibility and Post-Marketing Surveillance Study of Emollient Plus Medical Device Cream Containing Oligofructans from Ophiopogon japonicus and Acetyl Heptapeptide-4 in Atopic Dermatitis Skin Care
Abstract
Share and Cite
Rachalewski, M.; Pasikowska-Piwko, M.; Dębowska, R.; Marczak, I.; Lendzion, K.; Godziątkowski, H.; Czarnomysy, R.; Rogiewicz, K.; Eris, I. Biocompatibility and Post-Marketing Surveillance Study of Emollient Plus Medical Device Cream Containing Oligofructans from Ophiopogon japonicus and Acetyl Heptapeptide-4 in Atopic Dermatitis Skin Care. Cosmetics 2024, 11, 136. https://doi.org/10.3390/cosmetics11040136
Rachalewski M, Pasikowska-Piwko M, Dębowska R, Marczak I, Lendzion K, Godziątkowski H, Czarnomysy R, Rogiewicz K, Eris I. Biocompatibility and Post-Marketing Surveillance Study of Emollient Plus Medical Device Cream Containing Oligofructans from Ophiopogon japonicus and Acetyl Heptapeptide-4 in Atopic Dermatitis Skin Care. Cosmetics. 2024; 11(4):136. https://doi.org/10.3390/cosmetics11040136
Chicago/Turabian StyleRachalewski, Michał, Monika Pasikowska-Piwko, Renata Dębowska, Iwona Marczak, Karolina Lendzion, Hubert Godziątkowski, Robert Czarnomysy, Katarzyna Rogiewicz, and Irena Eris. 2024. "Biocompatibility and Post-Marketing Surveillance Study of Emollient Plus Medical Device Cream Containing Oligofructans from Ophiopogon japonicus and Acetyl Heptapeptide-4 in Atopic Dermatitis Skin Care" Cosmetics 11, no. 4: 136. https://doi.org/10.3390/cosmetics11040136